cidofovir anhydrous has been researched along with Arteriosclerosis in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bruggeman, CA; Bruning, JH; De Clercq, E; Lemström, K; Persoons, M; Stals, FS | 1 |
1 other study(ies) available for cidofovir anhydrous and Arteriosclerosis
Article | Year |
---|---|
Enhancement of transplantation-associated atherosclerosis by CMV, which can be prevented by antiviral therapy in the form of HPMPC.
Topics: Animals; Antiviral Agents; Aorta; Arteriosclerosis; Cidofovir; Cytomegalovirus; Cytomegalovirus Infections; Cytosine; Graft Rejection; Male; Organophosphonates; Organophosphorus Compounds; Postoperative Complications; Rats; Rats, Inbred BN; Rats, Inbred Lew; Transplantation, Homologous; Transplantation, Isogeneic; Tunica Intima; Tunica Media; Virus Replication | 1994 |